|
|
Volumn 22, Issue 1 II, 2002, Pages 30S-32S
|
|
Maximizing outcomes in respiratory tract infections in the age of resistance
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
LINCOSAMIDE;
MACROLIDE;
STREPTOGRAMIN;
TELITHROMYCIN;
AMOXICILLIN;
COTRIMOXAZOLE;
GATIFLOXACIN;
GEMIFLOXACIN;
KETOLIDE;
LEVOFLOXACIN;
METICILLIN;
MOXIFLOXACIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
STEROID;
ANTIBIOTIC RESISTANCE;
ANTIMICROBIAL THERAPY;
CHLAMYDOPHILA PNEUMONIAE;
CHRONIC BRONCHITIS;
CONFERENCE PAPER;
HAEMOPHILUS INFLUENZAE;
LEGIONELLA;
MORAXELLA CATARRHALIS;
MYCOPLASMA PNEUMONIAE;
PNEUMONIA;
RESPIRATORY TRACT INFECTION;
SOCIOECONOMICS;
STREPTOCOCCUS PNEUMONIAE;
TREATMENT OUTCOME;
ANTIMICROBIAL ACTIVITY;
COMMUNICABLE DISEASE;
ECONOMIC ASPECT;
PRACTICE GUIDELINE;
SPUTUM CULTURE;
|
|
EID: 0036139774
PISSN: 02770008
EISSN: None
Source Type: Journal
DOI: 10.1592/phco.22.2.1s.33133 Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (0)
|
